RU2567843C2 - Фармацевтические композиции сокристаллов трамадола и коксибов - Google Patents

Фармацевтические композиции сокристаллов трамадола и коксибов Download PDF

Info

Publication number
RU2567843C2
RU2567843C2 RU2012157256/15A RU2012157256A RU2567843C2 RU 2567843 C2 RU2567843 C2 RU 2567843C2 RU 2012157256/15 A RU2012157256/15 A RU 2012157256/15A RU 2012157256 A RU2012157256 A RU 2012157256A RU 2567843 C2 RU2567843 C2 RU 2567843C2
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
tramadol
pain
celecoxib
composition according
Prior art date
Application number
RU2012157256/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2012157256A (ru
Inventor
РАНСАНИ Луис СОЛЕР
АЛЬДЕА Альберт ФАЛИВЕНЕ
Original Assignee
Лабораторьос Дель Др. Эстеве, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораторьос Дель Др. Эстеве, С.А. filed Critical Лабораторьос Дель Др. Эстеве, С.А.
Publication of RU2012157256A publication Critical patent/RU2012157256A/ru
Application granted granted Critical
Publication of RU2567843C2 publication Critical patent/RU2567843C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
RU2012157256/15A 2010-06-04 2011-06-03 Фармацевтические композиции сокристаллов трамадола и коксибов RU2567843C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10384002.1 2010-06-04
EP10384002A EP2392319A1 (en) 2010-06-04 2010-06-04 Pharmaceutical compositions of co-crystals of tramadol and coxibs
PCT/EP2011/002749 WO2011151080A1 (en) 2010-06-04 2011-06-03 Pharmaceutical compositions of co-crystals of tramadol and coxibs

Publications (2)

Publication Number Publication Date
RU2012157256A RU2012157256A (ru) 2014-07-20
RU2567843C2 true RU2567843C2 (ru) 2015-11-10

Family

ID=42358396

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012157256/15A RU2567843C2 (ru) 2010-06-04 2011-06-03 Фармацевтические композиции сокристаллов трамадола и коксибов

Country Status (33)

Country Link
US (1) US8846744B2 (enExample)
EP (3) EP2392319A1 (enExample)
JP (1) JP5800016B2 (enExample)
KR (1) KR101556700B1 (enExample)
CN (1) CN102946871B (enExample)
AR (1) AR081774A1 (enExample)
AU (1) AU2011260608B2 (enExample)
CA (1) CA2798090C (enExample)
CO (1) CO6660469A2 (enExample)
CY (1) CY1118813T1 (enExample)
DK (1) DK2575778T3 (enExample)
EC (1) ECSP13012368A (enExample)
ES (1) ES2622192T3 (enExample)
HR (1) HRP20170594T1 (enExample)
HU (1) HUE033999T2 (enExample)
IL (1) IL222731A (enExample)
LT (1) LT2575778T (enExample)
MX (1) MX351507B (enExample)
MY (1) MY156859A (enExample)
NZ (1) NZ603457A (enExample)
PH (1) PH12012502171A1 (enExample)
PL (1) PL2575778T3 (enExample)
PT (1) PT2575778T (enExample)
RS (1) RS55878B1 (enExample)
RU (1) RU2567843C2 (enExample)
SG (1) SG185385A1 (enExample)
SI (1) SI2575778T1 (enExample)
SM (1) SMT201700261T1 (enExample)
TN (1) TN2012000515A1 (enExample)
TW (1) TWI508722B (enExample)
UA (1) UA109661C2 (enExample)
WO (1) WO2011151080A1 (enExample)
ZA (1) ZA201208767B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) * 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
US9138425B2 (en) 2013-03-12 2015-09-22 Patheon Inc. Drug delivery system to increase bioavailability
CA2947528C (en) 2014-05-01 2023-09-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
RU2016147008A (ru) * 2014-05-01 2018-06-04 Сан Фармасьютикал Индастриз Лимитед Жидкие композиции метформина с пролонгированным высвобождением
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
BR112017001968A2 (pt) 2014-07-30 2017-11-21 Sun Pharmaceutical Ind Ltd embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
WO2016046693A1 (en) * 2014-09-25 2016-03-31 Nathwani Sandeep Vinodkumar A co-processed pharmaceutical excipient
CN104276960B (zh) * 2014-09-26 2016-09-28 安徽省逸欣铭医药科技有限公司 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
WO2018031577A1 (en) * 2016-08-09 2018-02-15 Autotelic Llc Fixed dose combination for pain relief without edema
DE102016012746A1 (de) 2016-10-25 2018-04-26 WindplusSonne GmbH Vorprodukte zur Herstellung von porösen, mineralischen Leichtbaumaterialien, Verfahren zur Herstellung von porösen, mineralischen Leichtbaumaterialien und ihre Verwendung
JP2020510625A (ja) * 2016-12-14 2020-04-09 ナンジェネックス ナノテクノロジー インコーポレーテッドＮａｎｇｅｎｅｘ Ｎａｎｏｔｅｃｈｎｏｌｏｇｙ Ｉｎｃｏｒｐｏｒａｔｅｄ セレコキシブを含有する医薬組成物
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN110101673A (zh) * 2019-05-07 2019-08-09 安徽金太阳生化药业有限公司 一种盐酸曲马多分散片的制备方法
CA3137381A1 (en) * 2019-05-14 2020-11-19 Esteve Pharmaceuticals, S.A. Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadol
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途
SI4337169T1 (sl) * 2021-05-11 2026-05-29 Cingulate Therapeutics LLC Trimodalna tableta s časovno nastavljivim pulzirnim sproščanjem
CN115251264B (zh) * 2022-08-05 2023-11-21 齐鲁工业大学 含桑叶提取物的共结晶粉末功能性饮料及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138320A2 (de) * 2000-03-27 2001-10-04 Basf Aktiengesellschaft Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513924A (en) * 1999-03-01 2001-09-28 Ortho Mcneil Pharm Inc Composition comprising a tramadol material and a selective cox-2 inhibitor drug
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
PT1478366E (pt) * 2002-02-19 2009-03-10 Adcock Ingram Ltd Combinações farmacêuticas de meloxicam, fosfato de codeína e paracetamol
JP2005154334A (ja) * 2003-11-25 2005-06-16 Toa Yakuhin Kk アズレンスルホン酸塩水溶液剤
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
WO2008085674A1 (en) * 2007-01-04 2008-07-17 Transform Pharmaceuticals, Inc. Pharmaceutical compositions comprising celecoxib co-crystals
CN101254180B (zh) * 2008-03-28 2010-11-10 辽宁正鑫药物研究有限公司 一种内容物为半固体组合物的尼莫地平胶囊剂及制备方法
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138320A2 (de) * 2000-03-27 2001-10-04 Basf Aktiengesellschaft Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung

Also Published As

Publication number Publication date
US20130109659A1 (en) 2013-05-02
EP2575778B1 (en) 2017-01-18
RS55878B1 (sr) 2017-08-31
IL222731A (en) 2016-05-31
DK2575778T3 (en) 2017-04-18
KR20130093015A (ko) 2013-08-21
US8846744B2 (en) 2014-09-30
TW201143760A (en) 2011-12-16
MX2012014087A (es) 2013-02-27
HUE033999T2 (en) 2018-01-29
CA2798090C (en) 2017-02-28
MX351507B (es) 2017-10-18
ECSP13012368A (es) 2013-01-31
EP2392319A1 (en) 2011-12-07
AU2011260608A1 (en) 2012-11-22
CA2798090A1 (en) 2011-12-08
NZ603457A (en) 2014-10-31
IL222731A0 (en) 2012-12-31
SG185385A1 (en) 2012-12-28
SMT201700261T1 (it) 2017-07-18
AR081774A1 (es) 2012-10-17
PL2575778T3 (pl) 2017-09-29
PT2575778T (pt) 2017-04-21
CY1118813T1 (el) 2018-03-07
CO6660469A2 (es) 2013-04-30
ES2622192T3 (es) 2017-07-05
MY156859A (en) 2016-04-15
LT2575778T (lt) 2017-04-10
TWI508722B (zh) 2015-11-21
AU2011260608B2 (en) 2015-05-07
SI2575778T1 (sl) 2017-07-31
KR101556700B1 (ko) 2015-10-01
UA109661C2 (uk) 2015-09-25
EP3158994A1 (en) 2017-04-26
JP5800016B2 (ja) 2015-10-28
TN2012000515A1 (en) 2014-04-01
WO2011151080A1 (en) 2011-12-08
CN102946871B (zh) 2019-03-08
RU2012157256A (ru) 2014-07-20
PH12012502171A1 (en) 2016-02-24
JP2013530952A (ja) 2013-08-01
CN102946871A (zh) 2013-02-27
ZA201208767B (en) 2013-07-31
BR112012030704A2 (pt) 2016-09-13
EP2575778A1 (en) 2013-04-10
HRP20170594T1 (hr) 2017-06-16

Similar Documents

Publication Publication Date Title
JP5800016B2 (ja) トラマドールとコキシブとの共結晶の医薬品組成物
CA2992404C (en) Pharmaceutical composition containing celecoxib and tramadol
KR20200088382A (ko) 방출 제어 제제
RU2662562C2 (ru) Композиция в форме таблеток, содержащая гидрохлорид цинакалцета
CN113347975A (zh) 用于治疗侵蚀性手骨关节炎的孟鲁司特
US20130165459A1 (en) Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof
HK1180982A (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
HK1180982B (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
HK1180981A (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
EP2934485B1 (en) Tablet composition comprising cinacalcet hydrochloride
RU2804350C2 (ru) Фармацевтические композиции немедленного высвобождения, содержащие кетопрофена лизиновую соль
BR112012030704B1 (pt) Composição farmacêutica de cocristais e processo para sua produção
TW201618784A (zh) 用於減緩周邊血管疾病病患間歇性跛行症狀的屬喹啉酮衍生物之西洛他唑（ｃｉｌｏｓｔａｚｏｌ）的新穎調配物
JP2025036080A (ja) グアンファシンを含む医薬組成物及びその製造方法

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner